A new community hub at Orchard Park in Cambridge has opened and charities hope it will help break down barriers to help people access support. The Core community centre was opened by students at ...

Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of Vera Therapeutics (NasdaqGM:VERA) with a ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its price objective lifted by equities researchers at JPMorgan Chase & Co. from $51.00 to $53.00 in a report issued on Tuesday,Benzinga ...

Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is ...

Issues like increased noise, air pollution and traffic often arise, raising concerns about the impact of industrial parks on ...

Check the time stamp on this data. Updated AI-Generated Signals for Vera Therapeutics Inc. (VERA) available here: VERA. Type ...

Goldman Sachs has initiated coverage of Vera Therapeutics (VERA) with a buy rating, citing its drug candidate atacicept and a ...

Goldman Sachs analyst Paul Choi initiated coverage of Vera Therapeutics (VERA) with a Buy rating and $58 price target Following the recent ...

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have received a consensus recommendation of “Buy” from the nine brokerages that are presently covering the firm, Marketbeat reports.

Analyst Farzin Haque of Jefferies maintained a Buy rating on Vera Therapeutics (VERA – Research Report), with a price target of $58.00.Invest ...

On Friday, Vera Therapeutics Inc (VERA) stock saw a modest uptick, ending the day at $33.37 which represents a slight increase of $0.59 or 1.80% from the prior close of $32.78. The stock opened at $33 ...

It's been over two years since Kenny Doughty filmed his final scenes in Vera, and he will soon return to the small screen in a brand new drama, trading Brenda Blethyn for another globally renowned ...